BOLD

Boundless Bio (BOLD)

About Boundless Bio (BOLD)

Boundless Bio, Inc. is a clinical-stage oncology company, which is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA. The company was founded by Vineet Bafna, Paul Mischel, Benjamin F. Cravatt, and Jonathan E. Lim on April 10, 2018 and is headquartered in La Jolla, CA.

Details

Daily high

$2.50

Daily low

$2.38

Price at open

$2.45

52 Week High

$2.79

52 Week Low

$0.96

Market cap

54.2M

Dividend yield

0.00%

Volume

402,939

Avg. volume

4.0M

P/E ratio

-.96

Boundless Bio News